TY - JOUR
T1 - Measures of psychiatric symptoms in Alzheimer patients
T2 - A review
AU - Weiner, Myron F.
AU - Koss, Elisabeth
AU - Wild, Katherine V.
AU - Folks, David G.
AU - Tariot, Pierre
AU - Luszczynska, Halina
AU - Whitehouse, Peter
PY - 1996/3/14
Y1 - 1996/3/14
N2 - This review of instruments for the identification and quantification of psychiatric symptoms in Alzheimer disease (AD) is intended as a reference source for clinicians and researchers concerned with evaluating, quantifying, and managing psychiatric symptoms in AD. We review 16 clinician- and caregiver-rated scales selected from > 30 scales on the basis of their face validity, their psychometric properties, the frequency of their use, and their promise as assessment instruments. Instruments are described in terms of the population on which they were developed, the symptoms assessed, informant, by whom administered time to administer, time interval covered, number of items, measurement of frequency and severity, assessment of impact on caregiver, reliability, validity, and scoring. Recommendations are made concerning the best use of each scale. We summarize in table form the sources of information for instruments, characteristics of the instruments by domain, and potential use of instruments for quantification or management of symptoms and for estimation of caregiver burden. There are a number of reliable and valid scales for the assessment of psychiatric symptoms in AD, each with specific assets and liabilities. Knowledge of the specifics of these scales will enable clinicians and researchers to select the best instruments for their particular needs and to design more effective instruments.
AB - This review of instruments for the identification and quantification of psychiatric symptoms in Alzheimer disease (AD) is intended as a reference source for clinicians and researchers concerned with evaluating, quantifying, and managing psychiatric symptoms in AD. We review 16 clinician- and caregiver-rated scales selected from > 30 scales on the basis of their face validity, their psychometric properties, the frequency of their use, and their promise as assessment instruments. Instruments are described in terms of the population on which they were developed, the symptoms assessed, informant, by whom administered time to administer, time interval covered, number of items, measurement of frequency and severity, assessment of impact on caregiver, reliability, validity, and scoring. Recommendations are made concerning the best use of each scale. We summarize in table form the sources of information for instruments, characteristics of the instruments by domain, and potential use of instruments for quantification or management of symptoms and for estimation of caregiver burden. There are a number of reliable and valid scales for the assessment of psychiatric symptoms in AD, each with specific assets and liabilities. Knowledge of the specifics of these scales will enable clinicians and researchers to select the best instruments for their particular needs and to design more effective instruments.
KW - Alzheimer disease
KW - Psychiatric symptoms
UR - http://www.scopus.com/inward/record.url?scp=0029958868&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029958868&partnerID=8YFLogxK
U2 - 10.1097/00002093-199601010-00005
DO - 10.1097/00002093-199601010-00005
M3 - Article
C2 - 8919493
AN - SCOPUS:0029958868
SN - 0893-0341
VL - 10
SP - 20
EP - 30
JO - Alzheimer Disease and Associated Disorders
JF - Alzheimer Disease and Associated Disorders
IS - 1
ER -